Suppr超能文献

胱抑素 C 预测血肌酐处于正常上限的患者对比剂肾病:374 例前瞻性研究。

Prediction of contrast-induced nephropathy in patients with serum creatinine levels in the upper normal range by cystatin C: a prospective study in 374 patients.

机构信息

1 I. Medizinische Klinik, Klinikum rechts der Isar der Technischen Universität München, München, Germany.

出版信息

AJR Am J Roentgenol. 2014 Feb;202(2):452-8. doi: 10.2214/AJR.13.10688.

Abstract

OBJECTIVE

Preexisting renal impairment is a risk factor for contrast-induced nephropathy (CIN). In patients with creatinine in the upper normal level, cystatin C might be a more sensitive predictor of CIN than creatinine. Therefore, in this study, we investigated the usefulness of cystatin C to predict CIN.

SUBJECTS AND METHODS

In 400 consecutive patients with creatinine baseline levels between 0.8 and 1.3 mg/dL undergoing coronary angiography (n = 200) or CT (n = 200), baseline values of cystatin C, creatinine, blood urea nitrogen (BUN) and risk factors of CIN were determined. Creatinine was also assessed 24 and 48 hours after contrast administration.

RESULTS

Creatinine significantly (p < 0.001) increased after 24 hours and 48 hours compared with baseline (1.06 ± 0.28 and 1.07 ± 0.28 vs 0.99 ± 0.18 mg/dL). Fifty-three of 373 evaluable patients (14.2%) had an increase in creatinine of ≥ 25% or ≥ 0.5 mg/dL within 48 hours. CIN according to this definition was significantly more frequent after intraarterial contrast administration (38/190, 20%) compared with IV contrast administration (15/183, 8.2%; p = 0.001). CIN was predicted by baseline cystatin C (area under the receiver operating characteristic [ROC] curve [AUC], 0.715; p < 0.001), whereas creatinine, creatinine clearance, and BUN were not predictive. The best predictive capabilities were provided by cystatin C/creatinine-ratio (AUC, 0.826; p < 0.001). Multivariate regression analysis showed that intraarterial contrast administration (p = 0.002) and higher baseline cystatin C (p < 0.001) combined with low creatinine (p = 0.044) were independently associated with higher increases in creatinine within 48 hours after contrast administration.

CONCLUSION

CIN in patients with creatinine within the upper normal range is significantly more frequent after intraarterial than after IV contrast administration. In these patients, renal impairment after contrast administration is independently predicted by cystatin C and cystatin C/creatinine-ratio, whereas BUN and creatinine were not predictive.

摘要

目的

预先存在的肾功能损害是对比剂肾病(CIN)的一个危险因素。在肌酐处于正常值上限的患者中,胱抑素 C 可能比肌酐更能敏感地预测 CIN。因此,在这项研究中,我们研究了胱抑素 C 预测 CIN 的有用性。

对象和方法

在 400 例肌酐基线水平在 0.8 至 1.3mg/dL 之间行冠状动脉造影(n = 200)或 CT(n = 200)的连续患者中,测定了胱抑素 C、肌酐、血尿素氮(BUN)和 CIN 的危险因素的基线值。在造影后 24 小时和 48 小时也评估了肌酐。

结果

与基线相比,24 小时和 48 小时后肌酐显著(p < 0.001)增加(1.06 ± 0.28 和 1.07 ± 0.28 与 0.99 ± 0.18mg/dL)。在 373 例可评估患者中,有 53 例(14.2%)在 48 小时内肌酐升高≥25%或≥0.5mg/dL。根据这一定义,动脉内造影剂后 CIN 的发生率明显高于静脉造影剂后(38/190,20%比 15/183,8.2%;p = 0.001)。CIN 可由基线胱抑素 C 预测(接受者操作特征 [ROC]曲线下面积 [AUC],0.715;p < 0.001),而肌酐、肌酐清除率和 BUN 无预测价值。胱抑素 C/肌酐比值(AUC,0.826;p < 0.001)提供了最佳的预测能力。多变量回归分析显示,动脉内造影剂(p = 0.002)和较高的基线胱抑素 C(p < 0.001)结合较低的肌酐(p = 0.044)与造影后 48 小时内肌酐升高有关。

结论

在肌酐处于正常值上限的患者中,动脉内造影剂后 CIN 的发生率明显高于静脉内造影剂后。在这些患者中,造影后肾损伤可由胱抑素 C 和胱抑素 C/肌酐比值独立预测,而 BUN 和肌酐则不能预测。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验